AU2001273413A1 - Method for treating cancer using an interleukin- 4 antagonist - Google Patents
Method for treating cancer using an interleukin- 4 antagonistInfo
- Publication number
- AU2001273413A1 AU2001273413A1 AU2001273413A AU7341301A AU2001273413A1 AU 2001273413 A1 AU2001273413 A1 AU 2001273413A1 AU 2001273413 A AU2001273413 A AU 2001273413A AU 7341301 A AU7341301 A AU 7341301A AU 2001273413 A1 AU2001273413 A1 AU 2001273413A1
- Authority
- AU
- Australia
- Prior art keywords
- interleukin
- antagonist
- treating cancer
- cancer
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21788800P | 2000-07-12 | 2000-07-12 | |
US60/217,888 | 2000-07-12 | ||
PCT/US2001/022015 WO2002004009A2 (en) | 2000-07-12 | 2001-07-11 | Method for treating cancer using an interleukin- 4 antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001273413A1 true AU2001273413A1 (en) | 2002-01-21 |
Family
ID=22812896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001273413A Abandoned AU2001273413A1 (en) | 2000-07-12 | 2001-07-11 | Method for treating cancer using an interleukin- 4 antagonist |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020076409A1 (en) |
AU (1) | AU2001273413A1 (en) |
WO (1) | WO2002004009A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001272925A1 (en) | 2000-05-26 | 2001-12-11 | Immunex Corporation | Use of interleukin-4 antagonists and compositions thereof |
EP1434596B1 (en) * | 2001-10-09 | 2009-07-08 | Mayo Foundation For Medical Education And Research | Enhancement of immune responses by agonist 4-1bb-antibodies |
AU2003243189B2 (en) | 2002-05-01 | 2008-01-24 | Regeneron Pharmaceuticals, Inc. | Methods of using cytokine antagonists to treat HIV infection and AIDS |
US20070104710A1 (en) * | 2002-06-28 | 2007-05-10 | Domants Limited | Ligand that has binding specificity for IL-4 and/or IL-13 |
US20110223168A1 (en) * | 2002-12-27 | 2011-09-15 | Greg Winter | Ligand that has binding specificity for il-4 and/or il-13 |
EP1444989A1 (en) * | 2003-02-07 | 2004-08-11 | Giorgio Dr. Stassi | Sensitizing cells for apoptosis by selectively blocking cytokines |
US20060018829A1 (en) * | 2004-07-22 | 2006-01-26 | Smith Henry J | Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
EP1934375B1 (en) * | 2005-10-13 | 2015-04-15 | Hendrik Schulze-Koops | Means and methods for the prediction of joint destruction |
US20090215084A1 (en) * | 2006-01-05 | 2009-08-27 | Mayo Foundation For Medical Education And Research | B7-h1 and b7-h4 in cancer |
WO2007107349A1 (en) * | 2006-03-22 | 2007-09-27 | Apogenix Gmbh | Antibody specific for human il-4 for the treament of cancer |
ES2371287T3 (en) * | 2006-06-21 | 2011-12-29 | Apogenix Gmbh | DIFFERENTIAL EXPRESSION OF CITOCINE IN HUMAN CANCER. |
CA2656135A1 (en) * | 2006-07-06 | 2008-01-10 | Apogenix Gmbh | Human il-4 muteins in cancer therapy |
EP2205282A2 (en) * | 2007-09-24 | 2010-07-14 | Bar-Ilan University | Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
US8092804B2 (en) * | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
JP2011518128A (en) * | 2008-04-02 | 2011-06-23 | アポゲニクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | Binding agents for IL-4 receptors for the treatment of tumors, inflammatory disorders and immune disorders |
EP2596802A1 (en) | 2011-11-23 | 2013-05-29 | PLS-Design GmbH | Pharmaceutical composition for treatment of allergic reactions |
TWI573792B (en) | 2012-02-01 | 2017-03-11 | 歐陸斯迪公司 | Novel therapeutic agents |
EP2674168A1 (en) | 2012-06-14 | 2013-12-18 | PLS-Design GmbH | Modulation of effector T cell responses by local depletion of complement component C3 |
US9302005B2 (en) | 2013-03-14 | 2016-04-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
US10259875B2 (en) | 2013-10-01 | 2019-04-16 | Mayo Foundation For Medical Education And Research | Methods for treating cancer in patients with elevated levels of BIM |
WO2015179654A1 (en) | 2014-05-22 | 2015-11-26 | Mayo Foundation For Medical Education And Research | Distinguishing antagonistic and agonistic anti b7-h1 antibodies |
GB201409485D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
GB201409471D0 (en) * | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
GB201409488D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
WO2016014148A1 (en) | 2014-07-23 | 2016-01-28 | Mayo Foundation For Medical Education And Research | Targeting dna-pkcs and b7-h1 to treat cancer |
WO2017075045A2 (en) | 2015-10-30 | 2017-05-04 | Mayo Foundation For Medical Education And Research | Antibodies to b7-h1 |
CA3040155C (en) | 2016-10-11 | 2024-01-16 | Euro-Celtique S.A. | Compound for use in the treatment of hodgkin lymphoma |
GB201709402D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating t-pll |
GB201709406D0 (en) | 2017-06-13 | 2017-07-26 | Euro-Cletique S A | Compounds for treating TNBC |
GB201709405D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating ovarian cancer |
GB201709403D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating sarcoma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU643427B2 (en) * | 1988-10-31 | 1993-11-18 | Immunex Corporation | Interleukin-4 receptors |
MX9203401A (en) * | 1989-12-20 | 1992-07-01 | Schering Corp | ANTAGONIST ANTIBODIES OF HUMAN INTERLEUKINA-4. |
GB9124347D0 (en) * | 1991-11-15 | 1992-01-08 | Isis Innovation | Treatment of macrophages |
-
2001
- 2001-07-11 WO PCT/US2001/022015 patent/WO2002004009A2/en active Application Filing
- 2001-07-11 AU AU2001273413A patent/AU2001273413A1/en not_active Abandoned
- 2001-07-11 US US09/904,245 patent/US20020076409A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002004009A3 (en) | 2003-08-21 |
US20020076409A1 (en) | 2002-06-20 |
WO2002004009A2 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273413A1 (en) | Method for treating cancer using an interleukin- 4 antagonist | |
AU2651701A (en) | Method for introducing additives | |
AU2001227966A1 (en) | Methods for treating tumors | |
AU2001238126A1 (en) | Apparatus for local radiation therapy | |
AU2002350109A1 (en) | Methods and apparatus for cryo-therapy | |
AU2001238369A1 (en) | Method for treating thyroid disorders | |
AU2001264771A1 (en) | Well reference apparatus and method | |
AU2001264184A1 (en) | An invaginator apparatus | |
AU2002218140A1 (en) | Beam-shaping method | |
AU2001255602A1 (en) | Methods for treating bone tumors | |
AU2003287210A1 (en) | Method for treating emissions | |
AU2001249980A1 (en) | Apparatus for local radiation therapy | |
AUPR082200A0 (en) | An apparatus | |
AU2002225930A1 (en) | Methods for treating phosphatide-containing mixtures | |
AU2001276032A1 (en) | Method and apparatus for enhancing an applause | |
AU2001262978A1 (en) | Method and apparatus for interference reduction | |
AU2001277938A1 (en) | Method for treating angina | |
AU2002308642A1 (en) | Methods for treating cancer | |
AU2001253836A1 (en) | Method of treating cancer | |
AU2002214487A1 (en) | Method for inducing apoptiosis | |
AU5867901A (en) | Method for detecting tumors | |
AU2001236783A1 (en) | Apparatus for local radiation therapy | |
AU2001295036A1 (en) | Apparatus for performing microcurrentelectrotherapy | |
GB0123898D0 (en) | Method for treating objects | |
GB0118883D0 (en) | Method for treating objects |